You are now leaving the Kedrion Corporate site. The information available in your chosen website may not be in compliance with EU legislation regulating the advertising of medicinal products for human use, nor do the opinions expressed necessarily reflect the Company’s positions or are endorsed by it. In addition as per local health authority Regulations, some of our products are not approved for sales, marketing or distribution in all countries.
NO
YES

HIGHLIGHTS

CORPORATE

Kedrion’s Mother and Child Health campaign for Asia and MEA announced

Details were unveiled during our first televised Regional Distributor Meeting on July 14th-15th

read more 

CORPORATE

COVID-19. Kedrion partners with Columbia University Irving MC

Kedrion and Columbia University release video statements

read more 

EVENTS

ISTH, Kedrion supports symposium on the importance of inhibitor eradication

The central theme of the round table will be the optimization of the treatment of patients with Hemophilia A

read more 
  1. EVENTS - 16-04-2020

    Kedrion supports live streaming of medical debate on the use of convalescent plasma to treat Covid-19

    Online roundtable “The Gift of the Cured versus the Pandemic” on air at DonatoriH24 on April 16

    read more 
  2. CORPORATE - 07-04-2020

    Coronavirus, from Plasma an anti Covid-19 treatment

    Kedrion’s commitment to find a treatment from convalescent patient plasma

    read more 
  3. CORPORATE - 20-03-2020

    Letter to patient associations and scientific organizations

    Communication from Paolo Marcucci, Chairman & CEO of Kedrion

    read more 

Pages

For more information please contact: pressoffice@kedrion.com